Author:
Si Wen,Zhang Xuliang,Niu Yan,Yu Huiting,Lei Xiaoping,Chen Huanxin,Cao Xiaohua
Reference33 articles.
1. Potential role of muscarinic agonists in Alzheimer's disease;Avery;Drugs and Aging,1997
2. The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist;Bartolomeo;The Journal of Pharmacology and Experimental Therapeutics,2000
3. SDZ ENS 163, a selective muscarinic M1 receptor agonist, facilitates the induction of long-term potentiation in rat hippocampal slices;Boddeke;European Journal of Pharmacology,1992
4. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease;Bodick;Archives of Neurology,1997
5. Muscarinic receptor activation facilitates the induction of long-term potentiation (LTP) in the rat dentate gyrus;Burgard;Neuroscience Letters,1990
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献